CA2616159A1 - Benzimidazoles useful as inhibitors of protein kinases - Google Patents

Benzimidazoles useful as inhibitors of protein kinases Download PDF

Info

Publication number
CA2616159A1
CA2616159A1 CA002616159A CA2616159A CA2616159A1 CA 2616159 A1 CA2616159 A1 CA 2616159A1 CA 002616159 A CA002616159 A CA 002616159A CA 2616159 A CA2616159 A CA 2616159A CA 2616159 A1 CA2616159 A1 CA 2616159A1
Authority
CA
Canada
Prior art keywords
compound
independently
formula
optionally substituted
ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002616159A
Other languages
English (en)
French (fr)
Inventor
Hayley Binch
Michael Mortimore
Daniel Robinson
Dean Stamos
Simon Everitt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vertex Pharmaceuticals Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2616159A1 publication Critical patent/CA2616159A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
CA002616159A 2005-07-26 2006-07-21 Benzimidazoles useful as inhibitors of protein kinases Abandoned CA2616159A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70239905P 2005-07-26 2005-07-26
US60/702,399 2005-07-26
PCT/US2006/028149 WO2007015923A2 (en) 2005-07-26 2006-07-21 Benzimidazoles useful as inhibitors of protein kinases

Publications (1)

Publication Number Publication Date
CA2616159A1 true CA2616159A1 (en) 2007-02-08

Family

ID=37680602

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002616159A Abandoned CA2616159A1 (en) 2005-07-26 2006-07-21 Benzimidazoles useful as inhibitors of protein kinases

Country Status (17)

Country Link
US (1) US8076343B2 (cg-RX-API-DMAC7.html)
EP (2) EP1937667B1 (cg-RX-API-DMAC7.html)
JP (2) JP5255438B2 (cg-RX-API-DMAC7.html)
KR (1) KR20080034483A (cg-RX-API-DMAC7.html)
CN (1) CN101291927A (cg-RX-API-DMAC7.html)
AT (1) ATE484501T1 (cg-RX-API-DMAC7.html)
AU (1) AU2006276088A1 (cg-RX-API-DMAC7.html)
CA (1) CA2616159A1 (cg-RX-API-DMAC7.html)
DE (1) DE602006017574D1 (cg-RX-API-DMAC7.html)
ES (1) ES2351357T3 (cg-RX-API-DMAC7.html)
IL (1) IL188942A0 (cg-RX-API-DMAC7.html)
NO (1) NO20080967L (cg-RX-API-DMAC7.html)
NZ (1) NZ566021A (cg-RX-API-DMAC7.html)
RU (1) RU2415853C2 (cg-RX-API-DMAC7.html)
TW (1) TW200745088A (cg-RX-API-DMAC7.html)
WO (1) WO2007015923A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200800992B (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7989465B2 (en) 2007-10-19 2011-08-02 Avila Therapeutics, Inc. 4,6-disubstituted pyrimidines useful as kinase inhibitors
JP5600063B2 (ja) 2007-10-19 2014-10-01 セルジーン アビロミクス リサーチ, インコーポレイテッド ヘテロアリール化合物およびその使用
US9273077B2 (en) 2008-05-21 2016-03-01 Ariad Pharmaceuticals, Inc. Phosphorus derivatives as kinase inhibitors
JP2011523646A (ja) 2008-05-21 2011-08-18 アリアド・ファーマシューティカルズ・インコーポレイテッド キナーゼ阻害剤としてのリン誘導体
AU2012250517B2 (en) 2011-05-04 2016-05-19 Takeda Pharmaceutical Company Limited Compounds for inhibiting cell proliferation in EGFR-driven cancers
JP6469567B2 (ja) 2012-05-05 2019-02-13 アリアド・ファーマシューティカルズ・インコーポレイテッド Egfr発動性がんの細胞増殖阻害用化合物
US9336046B2 (en) 2012-06-15 2016-05-10 International Business Machines Corporation Transaction abort processing
US9512136B2 (en) * 2012-11-26 2016-12-06 Universal Display Corporation Organic electroluminescent materials and devices
EP2976336A1 (en) * 2013-03-21 2016-01-27 Bayer Pharma Aktiengesellschaft 3-heteroaryl substituted indazoles
US9611283B1 (en) 2013-04-10 2017-04-04 Ariad Pharmaceuticals, Inc. Methods for inhibiting cell proliferation in ALK-driven cancers
WO2014170421A1 (en) * 2013-04-19 2014-10-23 F. Hoffmann-La Roche Ag Serine/threonine kinase inhibitors
ITUA20164278A1 (it) * 2016-06-10 2017-12-10 International Soc For Drug Development S R L COMPOSTI 2-OXO-1,2-DIIDROPIRIDIN-3-CARBOSSAMMIDE E LORO USO COME INIBITORI DUALI DI PDK1/AurA
AU2018352695A1 (en) 2017-10-19 2020-05-28 Effector Therapeutics, Inc. Benzimidazole-indole inhibitors of Mnk1 and Mnk2
CN112552287B (zh) * 2020-12-16 2021-11-30 北京华氏精恒医药科技有限公司 一种吲哚类衍生物药物制剂及其制备方法
CN118055931A (zh) * 2021-12-23 2024-05-17 杭州多域生物技术有限公司 一种五元并六元化合物、制备方法、药物组合物和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE305465T1 (de) 1998-11-17 2005-10-15 Kumiai Chemical Industry Co Pyrimidinylbenzimidazol- und triazinylbenzimidazol-derivate und agrikulte/hortikulte fungizide
JP4535350B2 (ja) * 1998-11-17 2010-09-01 クミアイ化学工業株式会社 ピリミジニルベンズイミダゾール誘導体及び農園芸用殺菌剤
MXPA02003436A (es) * 1999-10-07 2002-08-20 Amgen Inc Inhibidores de triazina cinasa.
KR20030024659A (ko) 2000-02-17 2003-03-26 암겐 인코포레이티드 키나제 억제제
KR100833371B1 (ko) * 2001-04-27 2008-05-28 젠야쿠코교가부시키가이샤 헤테로시클릭 화합물 및 이를 유효 성분으로 하는 항종양제
FR2833948B1 (fr) * 2001-12-21 2004-02-06 Sod Conseils Rech Applic Nouveaux derives de benzimidazole et leur utilisation en tant que medicament
ATE457025T1 (de) * 2002-05-23 2010-02-15 Cytopia Res Pty Ltd Kinaseinhibitoren
AR042052A1 (es) * 2002-11-15 2005-06-08 Vertex Pharma Diaminotriazoles utiles como inhibidores de proteinquinasas
UA80767C2 (en) * 2002-12-20 2007-10-25 Pfizer Prod Inc Pyrimidine derivatives for the treatment of abnormal cell growth
ES2389203T3 (es) * 2004-01-12 2012-10-24 Ym Biosciences Australia Pty Ltd Inhibidores de quinasa selectivos

Also Published As

Publication number Publication date
AU2006276088A1 (en) 2007-02-08
EP1937667A2 (en) 2008-07-02
RU2415853C2 (ru) 2011-04-10
TW200745088A (en) 2007-12-16
US8076343B2 (en) 2011-12-13
ES2351357T3 (es) 2011-02-03
JP5255438B2 (ja) 2013-08-07
US20070099920A1 (en) 2007-05-03
CN101291927A (zh) 2008-10-22
ATE484501T1 (de) 2010-10-15
JP2009502921A (ja) 2009-01-29
ZA200800992B (en) 2009-09-30
JP2013082757A (ja) 2013-05-09
EP2336122A1 (en) 2011-06-22
DE602006017574D1 (de) 2010-11-25
NO20080967L (no) 2008-04-22
WO2007015923A3 (en) 2007-04-19
KR20080034483A (ko) 2008-04-21
WO2007015923A2 (en) 2007-02-08
EP2336122B1 (en) 2014-05-14
EP1937667B1 (en) 2010-10-13
IL188942A0 (en) 2008-04-13
WO2007015923A8 (en) 2008-04-03
RU2008106949A (ru) 2009-09-10
NZ566021A (en) 2011-03-31

Similar Documents

Publication Publication Date Title
AU2006315334B2 (en) Aminopyrimidines useful as kinase inhibitors
US7989456B2 (en) Pyrazine kinase inhibitors
EP3842427A1 (en) 1-cyano-pyrrolidine compounds as usp30 inhibitors
US20100022502A1 (en) Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases
JP2013082757A (ja) プロテインキナーゼ阻害薬として有用なベンズイミダゾール
US8455507B2 (en) Aminopyrimidines useful as kinase inhibitors
US20120165367A1 (en) Azaindazoles useful as inhibitors of kinases
KR20110039278A (ko) 단백질 키나제 억제제
HK1122558A (en) Benzimidazoles useful as inhibitors of protein kinases
MX2008001172A (en) Benzimidazoles useful as inhibitors of protein kinases
HK1161230A (en) Protein kinase inhibitors
HK1124323A (en) Pyrazine kinase inhibitors

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20130723